Revenue
2024
2025
| 2025 | 2024 | |
|---|---|---|
| Revenue | $90.9M | $86.9M |
| Gross profit | $54.4M | $58.3M |
| Research & development | $17.9M | $13.1M |
| Operating expenses | $83.2M | $75.8M |
| Operating income | −$28.8M | −$17.4M |
| EBITDAderived | −$16.8M | −$4.8M |
| Net income | −$4.1M | −$38.7M |
| Basic EPSper diluted share | -$0.17 | -$2.36 |
| Diluted EPSper diluted share | -$0.17 | -$2.36 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 17, 2026Form 4 | Pylypiv MariyaChief Financial Officer | SellCommon Stock | 30.0K | $7.66 | $230.0K | 80.2K |
| Apr 6, 2026Form 4/A | Uczekaj JohnPresident and COO | SellCommon Stock | 144 | $8.84 | $1.3K | 23.4K |
| Apr 6, 2026Form 4 | Uczekaj JohnPresident and COO | SellCommon Stock | 3.4K | $8.84 | $30.2K | 20.1K |
| Mar 12, 2026Form 4 | Uczekaj JohnPresident and COO | SellCommon Stock | 396 | $10.43 | $4.1K | 23.5K |
| Mar 12, 2026Form 4 | Pylypiv MariyaChief Financial Officer | SellCommon Stock | 20.1K | $10.26 | $206.0K | 49.9K |